Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,916 GBX | -0.80% | -5.67% | +6.93% |
May. 17 | HIKMA PHARMACEUTICALS : Time to capitalise on Hikma’s ongoing (share price) momentum | |
May. 03 | Deutsche Bank Starts Hikma Pharmaceuticals Coverage at Buy | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.93% | 5.45B | |
+37.78% | 723B | |
+31.40% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.40% | 244B | |
-4.62% | 208B | |
+10.19% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- Transcript : Hikma Pharmaceuticals PLC, 2022 Earnings Call, Feb 23, 2023